Kyung Nam Pharm Co Ltd (053950) — Capital Reinvestment Ratio
Latest as of September 2025:
0.20x
Kyung Nam Pharm Co Ltd (053950) has a Capital Reinvestment Ratio of 0.20x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩748.10 Million) in capital expenditures (₩147.39 Million). See 053950 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.20x
Capex / Operating Cash Flow
Operating Cash Flow
₩748.10 Million
KRW
Capital Expenditures
₩147.39 Million
KRW
Data as of
Sep 2025
Most recent filing
Kyung Nam Pharm Co Ltd Capital Reinvestment Ratio (2007–2024)
This chart tracks Kyung Nam Pharm Co Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Kyung Nam Pharm Co Ltd (2007–2024)
Year-by-year Capital Reinvestment Ratio for Kyung Nam Pharm Co Ltd from 2007 to 2024. For live market cap and broader valuation context, see 053950 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.91x | ₩1.84 Billion | ₩1.67 Billion | ▼ -85.0% |
| 2023 | 6.02x | ₩693.30 Million | ₩4.18 Billion | ▼ -85.2% |
| 2022 | 40.77x | ₩71.58 Million | ₩2.92 Billion | ▲ +133.9% |
| 2020 | 17.43x | ₩2.62 Billion | ₩45.58 Billion | ▲ +2749.8% |
| 2017 | 0.61x | ₩1.72 Billion | ₩1.05 Billion | ▲ +169.5% |
| 2016 | 0.23x | ₩4.89 Billion | ₩1.11 Billion | ▼ -99.0% |
| 2010 | 22.56x | ₩482.65 Million | ₩10.89 Billion | ▼ -15.9% |
| 2007 | 26.83x | ₩148.79 Million | ₩3.99 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow